A case report of naltrexone treatment of self-injury and social withdrawal in autism
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The endogenous opiate release theory of self-injurious behavior (SIB) was investigated through double-blind placebo-controlled administration of naltrexone hydrochloride (Trexan ®) to a 14-year-old autistic and mentally retarded male for treatment of severe SIB. Results yielded a marked decrease in SIB during two phases of active drug treatment, though SIB did not revert to originally observed placebo levels during a second placebo phase. An increase in social relatedness also was observed during phases of active drug treatment. Opiate theories of self-injury and the possible interrelationship of self-injury with pituitary-adrenal arousal and with social relatedness are discussed.
- Aman, M. G., Singh, N. N., Steward, A. W., & Field, C. J. (1985). The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects.American Journal of Mental Deficiency, 89, 485–491.
- Barrett, R. P. (1986).Severe behavior disorders in the mentally retarded: Nondrug approaches to treatment. New York: Plenum Press.
- Barrett, R. P., Feinstein, C., & Hole, W. T. (1989). Effects of naloxone and naltrexone on selfinjury: A double-blind, placebo controlled analysis.American Journal of Mental Retardation, 93, 644–651.
- Beckwith, B. E., Couk, D., & Schumaker, K. (1986). Failure of naloxone to reduce self-injurious behavior in two developmentally disabled females.Applied Research in Mental Retardation, 7, 183–188.
- Bernstein, G. A., Hughes, J., Mitchell, J. E., & Thompson, T. (1987). Effects of narcotic antagonists on self-injurious behavior: A single case study.Journal of the American Academy of Child and Adolescent Psychiatry, 26, 886–889.
- Campbell, M., Adams, P., Small, A., Tesch, L., & Curren, E. (1988). Naltrexone in infantile autism.Psychopharmacology Bulletin, 24, 135–139.
- Campbell, M., Overall, J. E., Small, A. M., Sokol, M. S., Spencer, E. K., Adams, P., Foltz, R. L., Monti, K. M., Perry, R., Nobler, M., & Roberts, E. (1989). Naltrexone in autistic children: An acute open dose range tolerance trial.Journal of the American Academy of Child and Adolescent Psychiatry, 28, 200–206.
- Carr, E. G. (1977). The motivation of self-injurious behavior: A review of some hypotheses.Psychological Bulletin, 84, 800–816.
- Cataldo, M. F., & Harris, J. (1982). The biological basis of self-injury in the mentally retarded.Analysis and Intervention in Developmental Disabilities, 2, 21–39.
- Davidson, P. W., Kleene, B. M., Carroll, M., & Rockowitz, R. J. (1983). Effects of naloxone on self-injurious behavior: A case study.Applied Research in Mental Retardation, 4, 1–4.
- Deutsch, S. I. (1986). Rationale for the administration of opiate antagonists in treating infantile autism.American Journal of Mental Deficiency, 90, 631–635.
- Freeman, B. J., Ritvo, E. R., Yokota, A., & Ritvo, A. (1986). A scale for rating symptoms of patients with autism in real life settings.Journal of the American Academy of Child Psychiatry, 25, 130–136.
- Herman, B. H., Hammock, M. K., Arthur-Smith, A., Egan, J., Chatoor, I., Werner, A., & Zelnek, N. (1987). Naltrexone decreases self-injurious behavior.Annals of Neurology, 22, 550–552.
- Hill, B. K., Balow, E. A., & Bruininks, R. H. (1985). A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.Psychopharmacology Bulletin, 21, 279–284.
- Kalat, J. (1978). Speculation on the similarities between autism and opiate addiction.Journal of Autism and Childhood Schizophrenia, 8, 477–479.
- Panksepp, J. (1979). A neurochemical theory of autism.Trends Neurosciences, 2, 174–177.
- Panksepp, J., & Sahley, T. J. (1987). Possible brain opioid involvement in disrupted social intent and language development of autism. In E. Shopler, & G. B. Mesibov (Eds.),Neurobiological issues in autism. New York: Plenum Press.
- Panksepp, J., Siviy, S. M., & Normansell, L. A. (1985). Brain opioids and social emotions. In M. Reite & T. Fields (Eds.),The psychobiology of attachment. New York: Academy Press.
- Richardson, J. S., & Zaleski, W. A. (1983). Naloxone and self-mutilation.Biological Psychiatry, 18, 99–101.
- Sahley, T. L., & Panksepp, J. (1987). Brain opioids and autism: An updated analysis of possible linkages.Journal of Autism and Developmental Disorders, 17, 201–216.
- Sandman, C. A., Datta, P. C., Baron, J., Hoehler, F. K., Williams, C., & Swanson, J. M. (1983). Naloxone attenuates self-abusive behavior in developmentally disabled clients.Applied Research in Mental Retardation, 4, 5–11.
- Sandyk, R. (1985). Naloxone abolishes self-injuring in a mentally retarded child.Annals of Neurology, 17, 520.
- Singh, N. N., & Millichamp, C. J. (1985). Pharmacological treatment of self-injurious behavior in mentally retarded persons.Journal of Autism and Developmental Disorders, 15, 257–267.
- Szymanski, L., Kedesky, J., Sulkes, S., Cutler, A., & Stevens-Ours, P. (1987). Naltrexone in treatment of self-injurious behavior: A clinical study.Research in Developmental Disabilities, 8, 179–190.
- A case report of naltrexone treatment of self-injury and social withdrawal in autism
Journal of Autism and Developmental Disorders
Volume 20, Issue 2 , pp 169-176
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- Industry Sectors